CEPHALALGIA

metrics 2024

Shaping the Future of Headache Management

Introduction

CEPHALALGIA is a prestigious peer-reviewed journal dedicated to the field of headache research and management, published by SAGE Publications Ltd. With a remarkable impact in the discipline, it holds the esteemed position of Q1 across both Medicine (miscellaneous) and Neurology (clinical) categories as of 2023, placing it in the top 10% of its field according to Scopus rankings. The journal has been actively contributing to the scientific community since 1981, offering a platform for groundbreaking studies, reviews, clinical guidelines, and original research articles that emphasize the complexities and multidimensional aspects of headache disorders. As a vital resource for clinicians, researchers, and students, CEPHALALGIA aims to enhance understanding and foster innovation in headache management, ultimately improving patient outcomes in this prevalent area of healthcare. Although it does not currently operate under an open access model, the journal's rigorous selection process ensures the publication of only the highest quality research, making it an essential reference for anyone serious about advancing knowledge in this critical domain.

Metrics 2024

SCIMAGO Journal Rank1.38
Journal Impact Factor5.00
Journal Impact Factor (5 years)6.90
H-Index143
Journal IF Without Self5.00
Eigen Factor0.01
Normal Eigen Factor2.74
Influence2.02
Immediacy Index2.00
Cited Half Life7.90
Citing Half Life7.40
JCI1.35
Total Documents4387
WOS Total Citations13079
SCIMAGO Total Citations45890
SCIMAGO SELF Citations5294
Scopus Journal Rank1.38
Cites / Document (2 Years)4.24
Cites / Document (3 Years)4.57
Cites / Document (4 Years)4.67

Metrics History

Rank 2024

Scopus

Neurology (clinical) in Medicine
Rank #39/400
Percentile 90.25
Quartile Q1

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 32/277
Percentile 88.60
Quartile Q1
NEUROSCIENCES
Rank 49/310
Percentile 84.40
Quartile Q1

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 36/278
Percentile 87.05
Quartile Q1
NEUROSCIENCES
Rank 47/310
Percentile 84.84
Quartile Q1

Quartile History

Similar Journals

NEUROLOGIC CLINICS

Transforming research into clinical practice.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

JOURNAL OF ASTHMA

Advancing knowledge in respiratory health.
Publisher: TAYLOR & FRANCIS LTDISSN: 0277-0903Frequency: 12 issues/year

The Journal of Asthma, published by Taylor & Francis Ltd, stands as a prominent platform for disseminating crucial research in the fields of respiratory health, particularly focusing on asthma and related conditions. With an impact factor reflecting its esteemed position—ranking in the second and third quartiles of categories such as Immunology and Allergy, Medicine (miscellaneous), Pediatrics, and Pulmonary and Respiratory Medicine—the journal provides comprehensive insights into the latest findings and advancements in clinical practice and research. The journal, which has been in circulation since 1963, embraces a multidisciplinary approach, catering to a diverse audience that includes researchers, healthcare professionals, and students. Although it does not offer open access, it remains a critical resource for those seeking to deepen their understanding of asthma pathology and treatment strategies. The Journal of Asthma continues to serve as a vital academic forum, advancing knowledge and prompting innovation in the management of this pervasive health issue.

Journal of Stroke

Leading the Charge in Stroke Awareness and Treatment
Publisher: KOREAN STROKE SOCISSN: 2287-6391Frequency: 3 issues/year

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

Advances in Rheumatology

Unlocking the potential of rheumatology through open access.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Journal of Asthma and Allergy

Bridging research and practice in pulmonary medicine.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6965Frequency: 1 issue/year

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

Current Pain and Headache Reports

Empowering Knowledge in Anesthesiology and Neurology
Publisher: SPRINGERISSN: 1531-3433Frequency: 12 issues/year

Current Pain and Headache Reports, published by SPRINGER, is a leading journal in the dynamic fields of anesthesiology, pain medicine, and clinical neurology. Since its inception in 2001, this journal has played a pivotal role in disseminating high-quality, peer-reviewed research that addresses the complex challenges associated with pain and headache disorders. With an impressive 2023 impact factor placing it in the Q1 quartile for Anesthesiology and Pain Medicine, and notable rankings in Clinical Neurology, it is a crucial resource for researchers, clinicians, and students seeking to advance their knowledge and practice in these vital areas of medicine. The journal supports a broad spectrum of scholarly activities by publishing original research, reviews, and expert opinion pieces, contributing significantly to the ongoing dialogue in pain management and headache treatment. As a subscription-based journal based in the United States, Current Pain and Headache Reports ensures that all articles meet rigorous scientific standards, fostering innovation and collaboration across multiple disciplines.

JOURNAL OF HEADACHE AND PAIN

Empowering Knowledge in Headache and Pain Medicine
Publisher: BMCISSN: 1129-2369Frequency: 1 issue/year

Journal of Headache and Pain, published by BMC, stands as a premier open-access platform dedicated to advancing research and practice in the fields of headache, pain medicine, and neurology. With its ISSN 1129-2369 and E-ISSN 1129-2377, this journal not only garners a significant global audience but also features a robust impact within the academic community, evidenced by its impressive rankings in 2023, placing it in the Q1 category for Anesthesiology and Pain Medicine, as well as Neurology (clinical), with Scopus ranks affirming its position among the top journals in its fields. Since its inception, the journal has provided a vital resource for researchers, professionals, and students, fostering collaboration and innovation through open access since 2011. The journal's scope encompasses interdisciplinary approaches to headache and pain management, offering insights that bridge clinical practice and research, thereby enhancing the understanding and treatment of these pervasive conditions. As it converges its efforts toward a continuous commitment to excellence through 2024 and beyond, the Journal of Headache and Pain remains an essential outlet for disseminating groundbreaking findings and facilitating knowledge exchange in a domain that profoundly impacts global health.

Journal of Oral & Facial Pain and Headache

Transforming research into practice for optimal patient outcomes.
Publisher: QUINTESSENCE PUBLISHING CO INCISSN: 2333-0384Frequency: 4 issues/year

Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Advancing knowledge in digestive health.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0954-691XFrequency: 12 issues/year

The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.

CURRENT OPINION IN NEUROLOGY

Navigating the Evolving Landscape of Neurology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.